Pfizer Covid Pill
-
{
- All
- News
- Videos
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
US Health Regulator Authorizes Pfizer's Covid Pill
The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.
-
European Union Medical Body Approves Pfizer Covid Pill For Emergency Use
The European Union's drug regulator on Thursday approved Pfizer's Covid pill for emergency use by individual member states struggling with the new wave of the disease, pending formal approval across the bloc.
-
Pfizer Covid Pill Nearly 90% Effective, Works On Omicron, Shows Lab Data
Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
US Health Regulator Authorizes Pfizer's Covid Pill
The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.
-
European Union Medical Body Approves Pfizer Covid Pill For Emergency Use
The European Union's drug regulator on Thursday approved Pfizer's Covid pill for emergency use by individual member states struggling with the new wave of the disease, pending formal approval across the bloc.
-
Pfizer Covid Pill Nearly 90% Effective, Works On Omicron, Shows Lab Data
Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
